96 related articles for article (PubMed ID: 16709987)
1. Indian pressure group challenges company's right to patent AIDS drug.
Mudur G
BMJ; 2006 May; 332(7551):1176. PubMed ID: 16709987
[No Abstract] [Full Text] [Related]
2. Generic HIV drugs will widen US treatment net.
Maxmen A
Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
[No Abstract] [Full Text] [Related]
3. Expert review of drug patent applications: improving health in the developing world.
Amin T; Rajkumar R; Radhakrishnan P; Kesselheim AS
Health Aff (Millwood); 2009; 28(5):w948-56. PubMed ID: 19706627
[TBL] [Abstract][Full Text] [Related]
4. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
5. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
6. Advantages of low-cost generic tenofovir instead of D4T for first-line antiretroviral therapy in Burma: a 2-year experience.
Moore S; Myint MM; Galau NH
AIDS; 2010 Jun; 24(10):1606-7. PubMed ID: 20539097
[No Abstract] [Full Text] [Related]
7. HIV clinics are halting enrolment of new patients as funding stalls, MSF warns.
Roehr B
BMJ; 2009 Jul; 339():b2966. PubMed ID: 19620230
[No Abstract] [Full Text] [Related]
8. Charities lobby EU over access to generic drugs.
Gulland A
BMJ; 2012 Feb; 344():e1066. PubMed ID: 22331320
[No Abstract] [Full Text] [Related]
9. Brands in peril as Brazil strives to keep AIDS drugs free.
Butler D
Nature; 2004 Jun; 429(6991):493. PubMed ID: 15175719
[No Abstract] [Full Text] [Related]
10. Patent. Battle lines are drawn over generic AIDS drug.
AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
[No Abstract] [Full Text] [Related]
11. Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
AIDS Treat News; 1999 Jun; (No 321):8. PubMed ID: 11366716
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
13. Global trade and access to medicines: AIDS treatments in Thailand.
Wilson D; Cawthorne P; Ford N; Aongsonwang S
Lancet; 1999 Nov; 354(9193):1893-5. PubMed ID: 10584741
[No Abstract] [Full Text] [Related]
14. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
[No Abstract] [Full Text] [Related]
15. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
16. AIDS drugs. Brazil, Thailand override big pharma patents.
Cohen J
Science; 2007 May; 316(5826):816. PubMed ID: 17495145
[No Abstract] [Full Text] [Related]
17. Closing the affordability gap for drugs in low-income countries.
Steinbrook R
N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
[No Abstract] [Full Text] [Related]
18. Indian biogenerics industry emerges.
Jayaraman KS
Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
[No Abstract] [Full Text] [Related]
19. New 20 year patents threaten to end AIDS drugs for developing countries.
Dyer O
BMJ; 2004 Dec; 329(7478):1308. PubMed ID: 15576738
[No Abstract] [Full Text] [Related]
20. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
